Express Pharma, the leading industry publication from The Indian Express Group, is organising the Sikkim Pharma Summit 2018. It is a one-day conference for the stakeholders of the pharma industry to be held in Gangtok, the capital city of Sikkim.
Under the theme, ‘Building India Advantage: Enhancing efficiencies, Maximising Value,’ experts and veterans of the industry will address critical issues such as:
• Transformation of the pharma industry, globally and in India
• Developing a robust, innovative ecosystem for pharma industry
• Strategies for implementation of international best practices
• Emerging manufacturing technologies and techniques
• Encouraging local R&D and attracting foreign investment
• Pricing policy and other regulatory challenges
Come, let’s collaborate to create a vibrant and robust ecosystem which will steer India Pharma Inc to greater heights.
Excise benefits to Pharma companies setting up manufacturing units in the state.
Home to Major pharma players such as Cipla, Sun Pharma, Zydus Cadila, Alembic, IPCA, Alkem Lab, Intas Pharma, Torrent Pharmaceuticals and Unichem
Policies such as The North East Industrial Investment Promotion Policy, 2007 Are Creating a conducive business climate
Institutional support from government agencies viz., North East Council, Ministry of Development of North Eastern Region and Commerce and Industries Department
FDI equity inflows worth $4.19 billion during the period April 2000 to December 2017
Source: IBEF Report
As one of the top 'pharmerging' markets, India is poised for a higher growth trajectory. An IBEF sector report on the Indian pharma industry predicts that by 2020, India is likely to be among the top three pharma markets by incremental growth and sixth largest market globally in absolute size.
But, moving up the value ladder is an imperative to realise our true potential. And, this calls for transformation into an innovation-driven industry through concerted measures on regulatory, market, scientific, and technological fronts; be it through infrastructure-building, technology transfer capabilities, skilling or IP creation.
Now is the time to bolster our inherent strengths and create new capabilities to derive a competitive edge and capitalise on the huge growth opportunity in the changing pharma landscape.
The Indian Express is one of India’s largest media conglomerates with a wide selection of publications and a network of offices spread across India. Today, with 32 national editions, 13 publication centers and 4 language dailies we reach over 19 million people daily.
The Express Group of publications has stood for excellence in journalism for over 80 years. Our Group publications include The Indian Express, The Financial Express, Loksatta, Lokprabha, Jansatta and The Business Publication Division.
Established in 1990, the Business Publications Division (BPD) of the Group manages B2B publications like Express Computer, Express Pharma, Express Healthcare, Express TravelWorld, Food and Hospitality World, as well as organizes marquee events like Technology Senate, Technology Sabha, Healthcare Senate, Healthcare Sabha, BFSI Technology Conclave.
Express Pharma, first published as Express Pharma Pulse in 1994, is today India’s leading business fortnightly for the pharmaceutical industry. The editorial contents include: news, views, analysis and interviews, under four main segments: Market (The business of pharmaceuticals), Management (Insight for managing pharma), Research (Expertise for drug development) and Pharma Life (HR issues with a pharma focus). Besides this, we bring out periodic specials like the quarterly Pharma Technology Review, Packaging Special and LABNEXT.
Rajesh Bhatkal, +919821313017, Email: [email protected], [email protected]
MUMBAI: Rajesh Bhatkal, +919821313017, Email: [email protected],[email protected]
AHMEDABAD: Nirav Mistry, +919586424033, Email: [email protected]
NEW DELHI: Ambuj Kumar, +919999070900, Email: [email protected]
HYDERABAD: E Mujahid, +919849039936, Email: [email protected]
BENGALURU : Rajesh Bhatkal, +919821313017, Email: [email protected],[email protected]
KOLKATA: Ajanta Sen Gupta, +919831182580, Email: [email protected]
Debnarayan Dutta, +919051150480, Email: [email protected]
Usha Sharma: +91 8169199462, [email protected]
Madhuri Kudapkar: +91 9664297646, Email: [email protected]
Regd Office: Express Towers, Nariman Point, Mumbai 400 021, Tel: 022 – 6744 0000, Fax: 022 – 22885831
CIN – U22120MH2003PLC142983